Mineralys Therapeutics, Inc.(MLYS),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

MLYS Mineralys Therapeutics, Inc.

Pre-Mkt 10-19 05:08:14 EDT

20.30

-1.34

-6.19%

盘前20.60

+0.30+1.48%

04:00 EDT

High21.60	Low20.12	Vol1.18M
Open21.60	D1 Closing21.64	Amplitude6.84%
Mkt Cap1.79B	Tradable Cap1.34B	Total Shares88.16M
T/O24.21M	T/O Rate1.79%	Tradable Shares66.03M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"MLYS","market":"US","secType":"STK","nameCN":"Mineralys Therapeutics, Inc.","latestPrice":20.3,"timestamp":1792180800000,"preClose":21.64,"halted":0,"volume":1181246,"hourTrading":{"tag":"盘前","latestPrice":20.6003,"preClose":20.3,"latestTime":"04:00 EDT","volume":1,"amount":20.6003,"timestamp":1792396854706,"change":0.3003,"changeRate":0.014793,"amplitude":0},"delay":0,"changeRate":-0.06192236598890942,"floatShares":66025800,"shares":88158500,"eps":-4.37633,"marketStatus":"Pre-Mkt","change":-1.34,"latestTime":"10-19 05:08:14 EDT","open":21.6,"high":21.6,"low":20.12,"amount":24208138.950072,"amplitude":0.068392,"askPrice":20.64,"askSize":121,"bidPrice":20.01,"bidSize":121,"shortable":3,"etf":0,"ttmEps":-4.37633,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1792416600000},"marketStatusCode":1,"adr":0,"listingDate":1676005200000,"exchange":"NASDAQ","adjPreClose":20.3,"preHourTrading":{"tag":"盘前","latestPrice":20.6003,"preClose":20.3,"latestTime":"04:00 EDT","volume":1,"amount":20.6003,"timestamp":1792396854706,"change":0.3003,"changeRate":0.014793,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":20.3,"preClose":20.3,"latestTime":"19:30 EDT","volume":21590,"amount":438459,"timestamp":1792193405391,"change":0,"changeRate":0,"amplitude":0.004926},"volumeRatio":0.7876414192876501,"impliedVol":1.5201,"impliedVolPercentile":1},"requestUrl":"/m/hq/s/MLYS/tweets","defaultTab":"tweets","newsList":[{"id":"2674808117","title":"Analysts’ Top Healthcare Picks: Vertex Pharmaceuticals (VRTX), Mineralys Therapeutics, Inc. (MLYS)","url":"https://stock-news.laohu8.com/highlight/detail?id=2674808117","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2674808117?lang=en_us&edition=fundamental","pubTime":"2026-10-12 21:20","pubTimestamp":1791811228,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Vertex Pharmaceuticals (VRTX) and Mineralys Therapeu...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-top-healthcare-picks-vertex-pharmaceuticals-vrtx-mineralys-therapeutics-inc-mlys-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-top-healthcare-picks-vertex-pharmaceuticals-vrtx-mineralys-therapeutics-inc-mlys-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU2468319806.SGD","LABU","MLYS","LU2089984988.USD","XBI","LU0566484027.USD","PBE","LU1674673428.USD","BK4137","LU1559883803.SGD","SG9999001176.USD","LU2362541273.HKD","BK4533","IE0002270589.USD","LU1035775433.USD","IBB","IE00B4R5TH58.HKD","LU1815336091.USD","IE0002141913.USD","LU0889565916.HKD","VERX","LU2417539215.USD","LU0058720904.USD","HCSG","TBXU","IE00BZ9MQY76.HKD","LU0432979614.USD","SGXZ57979304.SGD","LU1069344957.HKD","LU2237438978.USD","XLV","BK4567","BK4532","LU1674673691.USD","LU2236285917.USD","IE00B19Z9Z06.USD","VRTX","BK4585","GNMX","LU1585245621.USD","BBH","IE00BFTCPJ56.SGD","IE00B894F039.SGD","BIB","BK4139","LU1093756168.USD","LU0109394709.USD","LU1430594728.SGD","IBBQ","IDNA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674825323","title":"How Blood Pressure Target Data At Mineralys Therapeutics (MLYS) Has Changed Its Investment Story","url":"https://stock-news.laohu8.com/highlight/detail?id=2674825323","media":"Simply Wall St.","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2674825323?lang=en_us&edition=fundamental","pubTime":"2026-10-12 10:28","pubTimestamp":1791772118,"startTime":"0","endTime":"0","summary":"Mineralys Therapeutics reported new analyses from the pivotal Phase 3 Launch-HTN trial showing 46% of lorundrostat treated patients hit AHA/ACC systolic blood pressure targets at 12 weeks, alongside supportive Explore-OSA Phase 2 data in hypertensive adults with obstructive sleep apnea.\nThe breadth of late stage data around lorundrostat, including six completed trials and detailed blood pressure and sleep related endpoints, points to a maturing clinical package that could reshape how...","market":"sg","thumbnail":"https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/6111000-choice1-card/1788937617532","type":0,"news_type":0,"thumbnails":["https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/6111000-choice1-card/1788937617532"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-mlys/mineralys-therapeutics/news/how-blood-pressure-target-data-at-mineralys-therapeutics-mly","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-mlys/mineralys-therapeutics/news/how-blood-pressure-target-data-at-mineralys-therapeutics-mly","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["MLYS","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674841739","title":"UBS Initiates a Hold Rating on Mineralys Therapeutics, Inc. (MLYS)","url":"https://stock-news.laohu8.com/highlight/detail?id=2674841739","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2674841739?lang=en_us&edition=fundamental","pubTime":"2026-10-12 06:57","pubTimestamp":1791759431,"startTime":"0","endTime":"0","summary":"In a report released today, from UBS initiated coverage with a Hold rating on Mineralys Therapeutics, Inc. and a price target of $29.00. Mineralys ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/ubs-initiates-a-hold-rating-on-mineralys-therapeutics-inc-mlys-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/ubs-initiates-a-hold-rating-on-mineralys-therapeutics-inc-mlys-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MLYS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674708854","title":"Mineralys Says Phase 3 Launch-HTN Trial Shows 46% of Lorundrostat Patients Hit SBP Target Below 130 mmHg at Week 12","url":"https://stock-news.laohu8.com/highlight/detail?id=2674708854","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2674708854?lang=en_us&edition=fundamental","pubTime":"2026-10-09 21:00","pubTimestamp":1791550857,"startTime":"0","endTime":"0","summary":"Mineralys says Phase 3 Launch-HTN trial shows 46% of lorundrostat patients hit SBP target below 130 mmHg at week 12Mineralys Therapeutics presented new analyses on lorundrostat at the American Heart A","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261009:nNDL6QrNmm:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999014021.USD","LU2210149790.SGD","SG9999014005.SGD","BK4139","IE00BKPKM429.USD","IE00BN0W2W23.USD","BCDF","BK4585","LU2095319765.USD","BK4112","NDAQ","LU0314104364.USD","IE00BQXX3F31.USD","SG9999014013.SGD","BK4588","SG9999014039.USD","IE00BGHQF748.EUR","IE00B64PRP62.GBP","LU2210150020.SGD","IE00BQXX3C00.GBP","IE00BN0W2T93.GBP","IE00B3QW5Z07.USD","MLYS","IE00BN0W2V16.EUR","IE00BQXX3D17.EUR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672727325","title":"Will AHA Trial Data Change Mineralys Therapeutics (MLYS) Narrative","url":"https://stock-news.laohu8.com/highlight/detail?id=2672727325","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672727325?lang=en_us&edition=fundamental","pubTime":"2026-10-04 14:15","pubTimestamp":1791094513,"startTime":"0","endTime":"0","summary":"Mineralys Therapeutics reported that long term efficacy and safety data from its Transform-HTN open label lorundrostat trial will be presented as late breaking science at the American Heart Association Scientific Sessions 2026 in Chicago.\nThe focus on uncontrolled and resistant hypertension, chronic kidney disease and obstructive sleep apnea highlights how lorundrostat could support a multi indication cardiorenal portfolio if future approvals are achieved.\nWe assess how Mineralys...","market":"sg","thumbnail":"https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/6111000-choice1-card/1788937617532","type":0,"news_type":0,"thumbnails":["https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/6111000-choice1-card/1788937617532"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-mlys/mineralys-therapeutics/news/will-aha-trial-data-change-mineralys-therapeutics-mlys-narra","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-mlys/mineralys-therapeutics/news/will-aha-trial-data-change-mineralys-therapeutics-mlys-narra","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["MLYS","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672741458","title":"Mineralys Therapeutics CEO Jon Congleton Disposes of $1,909,665 Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2672741458","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672741458?lang=en_us&edition=fundamental","pubTime":"2026-10-03 05:54","pubTimestamp":1790978045,"startTime":"0","endTime":"0","summary":"Mineralys Therapeutics CEO Jon Congleton disposes of $1,909,665 common sharesMineralys Therapeutics CEO Jon Congleton sold 75,000 common shares on Sept. 30, 2026.Weighted-average sale price USD 25.462","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261002:nNDL40rk7H:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Mineralys Therapeutics CEO Jon Congleton Disposes of $1,909,665 Common Shares","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","MLYS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672749635","title":"Mineralys Therapeutics to Present New Lorundrostat Launch-HTN Data at ASN Kidney Week 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2672749635","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672749635?lang=en_us&edition=fundamental","pubTime":"2026-10-03 04:30","pubTimestamp":1790973019,"startTime":"0","endTime":"0","summary":"Mineralys Therapeutics to present new lorundrostat Launch-HTN data at ASN Kidney Week 2026Mineralys Therapeutics disclosed new Launch-HTN trial data on lorundrostat will be presented at ASN Kidney Wee","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261002:nNDL3KqxNs:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999014039.USD","LU2210150020.SGD","BK4112","SG9999014021.USD","IE00BN0W2W23.USD","IE00BN0W2V16.EUR","SG9999014013.SGD","SG9999014005.SGD","IE00B64PRP62.GBP","NDAQ","IE00BKPKM429.USD","IE00BQXX3D17.EUR","BCDF","MLYS","LU2210149790.SGD","BK4139","BK4585","BK4588","IE00BQXX3F31.USD","IE00BGHQF748.EUR","LU0314104364.USD","IE00BQXX3C00.GBP","LU2095319765.USD","IE00BN0W2T93.GBP","IE00B3QW5Z07.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672649237","title":"Mineralys to Present Lorundrostat Explore-OSA Hypertension Trial Data at AHA Hypertension Scientific Sessions 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2672649237","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672649237?lang=en_us&edition=fundamental","pubTime":"2026-10-02 04:06","pubTimestamp":1790885167,"startTime":"0","endTime":"0","summary":"Mineralys to present lorundrostat Explore-OSA hypertension trial data at AHA Hypertension Scientific Sessions 2026Mineralys Therapeutics announced new clinical and preclinical lorundrostat data will b","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261001:nNDL40G0wH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BGHQF748.EUR","LU2210150020.SGD","IE00B64PRP62.GBP","BK4585","IE00BQXX3C00.GBP","IE00BN0W2V16.EUR","MLYS","NDAQ","IE00BKPKM429.USD","IE00B3QW5Z07.USD","LU2210149790.SGD","IE00BQXX3D17.EUR","IE00BN0W2W23.USD","IE00BQXX3F31.USD","BK4139","SG9999014005.SGD","IE00BN0W2T93.GBP","BCDF","BK4112","BK4588","SG9999014039.USD","SG9999014021.USD","LU0314104364.USD","LU2095319765.USD","SG9999014013.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671242133","title":"Mineralys Therapeutics Reports Inducement Awards Under NASDAQ Listing Rule 5635(c)(4)","url":"https://stock-news.laohu8.com/highlight/detail?id=2671242133","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671242133?lang=en_us&edition=fundamental","pubTime":"2026-09-30 04:05","pubTimestamp":1790712300,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260929:nTUABLCFB2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["MLYS","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670411008","title":"Mineralys Director Brian Taylor Slingsby Disposes of 104,320 Common Shares for $3 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2670411008","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670411008?lang=en_us&edition=fundamental","pubTime":"2026-09-25 09:50","pubTimestamp":1790301017,"startTime":"0","endTime":"0","summary":"Mineralys director Brian Taylor Slingsby disposes of 104,320 common shares for $3 millionMineralys Therapeutics director Brian Taylor Slingsby disclosed a sale of 104,320 common shares on Sep. 22, 202","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260925:nNDLb7th0x:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Mineralys Director Brian Taylor Slingsby Disposes of 104,320 Common Shares for $3 Million","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","MLYS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670141889","title":"Mineralys Therapeutics Joins Stifel Virtual Cardiometabolic Forum Fireside Chat","url":"https://stock-news.laohu8.com/highlight/detail?id=2670141889","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670141889?lang=en_us&edition=fundamental","pubTime":"2026-09-25 04:05","pubTimestamp":1790280357,"startTime":"0","endTime":"0","summary":"Mineralys Therapeutics joins Stifel Virtual Cardiometabolic Forum fireside chatMineralys Therapeutics management will join the Stifel 2026 Virtual Cardiometabolic Forum on Sept. 30, 2026.Session sched","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260924:nNDL28VNwW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","BK4127","IE00BQXX3D17.EUR","LU0314104364.USD","SF","SG9999014021.USD","IE00BN0W2V16.EUR","BCDF","IE00B3QW5Z07.USD","BK4585","BK4139","IE00BKPKM429.USD","LU2210150020.SGD","IE00BQXX3F31.USD","SG9999014013.SGD","NDAQ","SG9999014005.SGD","BK4112","IE00BN0W2W23.USD","MLYS","IE00BQXX3C00.GBP","IE00BN0W2T93.GBP","SG9999014039.USD","LU2095319765.USD","IE00B64PRP62.GBP","LU2210149790.SGD","IE00BGHQF748.EUR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669436381","title":"Mineralys Says Transform-HTN Extension Data on Lorundrostat Set for Late-Breaking AHA 2026 Presentation","url":"https://stock-news.laohu8.com/highlight/detail?id=2669436381","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669436381?lang=en_us&edition=fundamental","pubTime":"2026-09-24 04:06","pubTimestamp":1790193969,"startTime":"0","endTime":"0","summary":"Mineralys says Transform-HTN extension data on lorundrostat set for late-breaking AHA 2026 presentationMineralys Therapeutics flagged new long-term efficacy and safety findings from its Transform-HTN ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260923:nNDL9FfqgG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BQXX3C00.GBP","MLYS","IE00B64PRP62.GBP","IE00BQXX3D17.EUR","BK4112","SG9999014005.SGD","LU2095319765.USD","BCDF","IE00BN0W2T93.GBP","LU2210149790.SGD","SG9999014013.SGD","LU0314104364.USD","SG9999014021.USD","IE00BQXX3F31.USD","BK4585","BK4139","IE00B3QW5Z07.USD","NDAQ","IE00BN0W2V16.EUR","IE00BN0W2W23.USD","IE00BGHQF748.EUR","SG9999014039.USD","BK4588","IE00BKPKM429.USD","LU2210150020.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669120714","title":"Mineralys Therapeutics Chief Commercial Officer Eric Warren Disposes of Common Shares Worth USD 209,111.85","url":"https://stock-news.laohu8.com/highlight/detail?id=2669120714","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669120714?lang=en_us&edition=fundamental","pubTime":"2026-09-23 06:49","pubTimestamp":1790117356,"startTime":"0","endTime":"0","summary":"Mineralys Therapeutics Chief Commercial Officer Eric Warren disposes of common shares worth USD 209,111.85Mineralys Therapeutics Chief Commercial Officer Eric Warren sold 7,438 shares on Sept. 21, 202","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260922:nNDL5S6NXS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Mineralys Therapeutics Chief Commercial Officer Eric Warren Disposes of Common Shares Worth USD 209,111.85","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MLYS","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669198968","title":"Mineralys Therapeutics Reports Inducement Awards Under NASDAQ Listing Rule 5635(c)(4)","url":"https://stock-news.laohu8.com/highlight/detail?id=2669198968","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669198968?lang=en_us&edition=fundamental","pubTime":"2026-09-22 04:05","pubTimestamp":1790021100,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260921:nTUA48LYGW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["MLYS","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668997753","title":"Mineralys Therapeutics Director Daphne Karydas Sells 3,000 Shares for $85,740","url":"https://stock-news.laohu8.com/highlight/detail?id=2668997753","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668997753?lang=en_us&edition=fundamental","pubTime":"2026-09-18 05:41","pubTimestamp":1789681316,"startTime":"0","endTime":"0","summary":"Mineralys Therapeutics director Daphne Karydas sells 3,000 shares for $85,740Mineralys Therapeutics director Daphne Karydas sold 3,000 common shares at USD 28.58 on Sep. 15, 2026.She exercised stock o","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260917:nNDL2gSYPZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Mineralys Therapeutics Director Daphne Karydas Sells 3,000 Shares for $85,740","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","MLYS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666537260","title":"Mineralys Therapeutics Grants Inducement Equity Awards Covering 52,080 Shares to New Hires","url":"https://stock-news.laohu8.com/highlight/detail?id=2666537260","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666537260?lang=en_us&edition=fundamental","pubTime":"2026-09-10 04:06","pubTimestamp":1788984406,"startTime":"0","endTime":"0","summary":"Mineralys Therapeutics grants inducement equity awards covering 52,080 shares to new hiresMineralys granted inducement stock options covering 29,760 shares, plus inducement restricted stock units cove","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260909:nNDL2fRnMs:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2210149790.SGD","LU2210150020.SGD","IE00BN0W2V16.EUR","IE00B64PRP62.GBP","LU0314104364.USD","SG9999014005.SGD","SG9999014021.USD","BCDF","NDAQ","IE00BGHQF748.EUR","SG9999014013.SGD","LU2095319765.USD","BK4112","BK4585","BK4139","IE00BQXX3C00.GBP","BK4588","IE00BQXX3D17.EUR","MLYS","SG9999014039.USD","IE00BKPKM429.USD","IE00B3QW5Z07.USD","IE00BN0W2T93.GBP","IE00BN0W2W23.USD","IE00BQXX3F31.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666537455","title":"Mineralys Therapeutics Reports Inducement Awards Under NASDAQ Listing Rule 5635(c)(4)","url":"https://stock-news.laohu8.com/highlight/detail?id=2666537455","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666537455?lang=en_us&edition=fundamental","pubTime":"2026-09-10 04:05","pubTimestamp":1788984300,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260909:nTUA7GC4KF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["MLYS","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662751716","title":"Mineralys Therapeutics Joins Wells Fargo Annual Healthcare Conference Fireside Chat","url":"https://stock-news.laohu8.com/highlight/detail?id=2662751716","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662751716?lang=en_us&edition=fundamental","pubTime":"2026-08-26 20:02","pubTimestamp":1787745779,"startTime":"0","endTime":"0","summary":"Mineralys Therapeutics joins Wells Fargo annual healthcare conference fireside chatMineralys Therapeutics will participate in the Wells Fargo 21st Annual Healthcare Conference in Boston on Sept. 8-10,","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260826:nNDLbHj4C:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B3QW5Z07.USD","SG9999014021.USD","IE00BKPKM429.USD","BK4588","BK4139","LU2210149790.SGD","NDAQ","IE00BN0W2T93.GBP","BK4112","BCDF","IE00BGHQF748.EUR","LU0314104364.USD","IE00BN0W2V16.EUR","IE00BN0W2W23.USD","LU2095319765.USD","IE00B64PRP62.GBP","SG9999014013.SGD","IE00BQXX3F31.USD","IE00BQXX3C00.GBP","BK4585","LU2210150020.SGD","SG9999014039.USD","SG9999014005.SGD","MLYS","IE00BQXX3D17.EUR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662831718","title":"Mineralys Chief Commercial Officer Eric Warren Disposes of 7,437 Common Shares Worth $193,226","url":"https://stock-news.laohu8.com/highlight/detail?id=2662831718","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662831718?lang=en_us&edition=fundamental","pubTime":"2026-08-26 18:45","pubTimestamp":1787741125,"startTime":"0","endTime":"0","summary":"Mineralys Chief Commercial Officer Eric Warren disposes of 7,437 common shares worth $193,226Mineralys Therapeutics Chief Commercial Officer Eric Warren sold 7,437 common shares on Aug. 21.Sale priced","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260826:nNDL1RgTZp:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Mineralys Chief Commercial Officer Eric Warren Disposes of 7,437 Common Shares Worth $193,226","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MLYS","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661121126","title":"Why Mineralys Therapeutics (MLYS) Is Getting Fresh Attention","url":"https://stock-news.laohu8.com/highlight/detail?id=2661121126","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661121126?lang=en_us&edition=fundamental","pubTime":"2026-08-23 00:24","pubTimestamp":1787415872,"startTime":"0","endTime":"0","summary":"Why Mineralys Therapeutics Stock Is In Focus After Earnings And Leadership Change\nMineralys Therapeutics (MLYS) is on investors’ radar after second quarter 2026 results showed a net loss of US$241.07 million, alongside the appointment of James J. Ferguson III, M.D., as Chief Medical Officer.\nSee our latest analysis for Mineralys Therapeutics.\nMineralys Therapeutics’ recent news arrives after a mixed run for investors, with the share price down 5.04% over 30 days and 14.07% over 90 days, yet a...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-mlys/mineralys-therapeutics/news/why-mineralys-therapeutics-mlys-is-getting-fresh-attention","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-mlys/mineralys-therapeutics/news/why-mineralys-therapeutics-mlys-is-getting-fresh-attention","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4139","MLYS"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.mineralystx.com;www.ir.mineralystx.com","stockEarnings":[{"period":"1week","weight":-0.1314},{"period":"1month","weight":-0.2629},{"period":"3month","weight":-0.2506},{"period":"6month","weight":-0.3362},{"period":"1year","weight":-0.5276},{"period":"ytd","weight":-0.4406}],"compareEarnings":[{"period":"1week","weight":-0.0197},{"period":"1month","weight":0.0122},{"period":"3month","weight":0.0269},{"period":"6month","weight":0.0748},{"period":"1year","weight":0.1553},{"period":"ytd","weight":0.1193}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Mineralys Therapeutics, Inc., a clinical-stage biopharmaceutical company that develops therapies for the treatment of hypertension and associated cardiovascular diseases. It clinical-stage product candidate is lorundrostat, a proprietary, orally administered, highly selective aldosterone synthase inhibitor for the treatment of patients with uncontrolled or resistant hypertension. The company was incorporated in 2019 and is headquartered in Radnor, Pennsylvania.","yearOnYearQuotes":[{"month":1,"riseRate":0.333333,"avgChangeRate":-0.014493},{"month":2,"riseRate":0.333333,"avgChangeRate":0.081442},{"month":3,"riseRate":0.25,"avgChangeRate":0.095856},{"month":4,"riseRate":0,"avgChangeRate":-0.078413},{"month":5,"riseRate":1,"avgChangeRate":0.100473},{"month":6,"riseRate":0.25,"avgChangeRate":-0.046559},{"month":7,"riseRate":0.5,"avgChangeRate":-0.030144},{"month":8,"riseRate":0.75,"avgChangeRate":0.002547},{"month":9,"riseRate":0.25,"avgChangeRate":0.286264},{"month":10,"riseRate":0.5,"avgChangeRate":-0.049242},{"month":11,"riseRate":0.333333,"avgChangeRate":-0.0429},{"month":12,"riseRate":0.333333,"avgChangeRate":0.032291}],"exchange":"NASDAQ","name":"Mineralys Therapeutics, Inc.","nameEN":"Mineralys Therapeutics, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.50.1","shortVersion":"4.50.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Mineralys Therapeutics, Inc.(MLYS),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Mineralys Therapeutics, Inc.(MLYS) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Mineralys Therapeutics, Inc.,MLYS,Mineralys Therapeutics, Inc.股票,Mineralys Therapeutics, Inc.股票老虎,Mineralys Therapeutics, Inc.股票老虎国际,Mineralys Therapeutics, Inc.行情,Mineralys Therapeutics, Inc.股票行情,Mineralys Therapeutics, Inc.股价,Mineralys Therapeutics, Inc.股市,Mineralys Therapeutics, Inc.股票价格,Mineralys Therapeutics, Inc.股票交易,Mineralys Therapeutics, Inc.股票购买,Mineralys Therapeutics, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Mineralys Therapeutics, Inc.(MLYS),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Mineralys Therapeutics, Inc.(MLYS) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction